[2]
Wang W, Rong Z, Wang G, Hou Y, Yang F, Qiu M. Cancer metabolites: promising biomarkers for cancer liquid biopsy. Biomark Res 2023; 11(1): 66.
[3]
Debela DT, Muzazu SG, Heraro KD, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med 2021; 9: 20503121211034366.
[4]
Liu C, Shi Q, Huang X, Koo S, Kong N, Tao W. mRNA-based cancer therapeutics. Nat Rev Cancer 2023; 23(8): 526-43.
[5]
Kim T, Croce CM. MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med 2023; 55(7): 1314-21.
[6]
Li J, Chen H, Sun G, Zhang X, Ye H, Wang P. Role of miR-21 in the diagnosis of colorectal cancer: Meta-analysis and bioinformatics. Pathol Res Pract 2023; 248: 154670.
[7]
Abo-Elela DA, Salem AM, Swellam M, Hegazy MG. Potential diagnostic role of circulating MiRNAs in colorectal cancer. Int J Immunopathol Pharmacol 2023; 37: 3946320221144565.
[8]
Goyal R, Chopra H, Singh I, Dua K, Gautam RK. Insights on prospects of nano-siRNA based approaches in treatment of Cancer. Front Pharmacol 2022; 13: 985670.
[http://dx.doi.org/10.3389/fphar.2022.985670]
[http://dx.doi.org/10.3389/fphar.2022.985670]
[9]
Kim WR, Park EG, Lee DH, Lee YJ, Bae WH, Kim HS. The tumorigenic role of circular RNA-MicroRNA Axis in cancer. Int J Mol Sci 2023; 24(3): 3050.
[10]
Jia Z, An J, Liu Z, Zhang F. Non-coding RNAs in colorectal cancer: their functions and mechanisms. Front Oncol 2022; 12: 783079.
[11]
Wu F, Zhang L, Wu P. Wu Y. Zhang T. Zhang D. Tian J. The potential role of small nucleolar RNAs in cancers - an evidence map. Int J Gen Med 2022; 15: 3851-64.
[http://dx.doi.org/10.2147/IJGM.S352333] [PMID: 35431571] [PMCID: PMC9005336]
[http://dx.doi.org/10.2147/IJGM.S352333] [PMID: 35431571] [PMCID: PMC9005336]
[12]
Wang C, Gan L, Gao Z, Shen Z, Jiang K, Ye Y. Young adults with colon cancer: clinical features and surgical outcomes. BMC Gastroenterol 2023; 23(1): 192.
[13]
Castelo M, Paszat L, Hansen BE, Scheer AS, Faught N, Nguyen L, Baxter NN. Analysis of time to treatment and survival among adults younger than 50 years of age with colorectal cancer in Canada. JAMA Net Open 2023; 6(8): e2327109.